ArticleBlood cancer journal2024

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Thomas Lund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.